To confirm the biological relevance of bipDARPin-induced lockdown of HER2, we employed the small (6 kDa) affibody Zher2 (ref. 22) for labeling endogenous, untagged HER2 in breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.